Luis Concha News Today

/PRNewswire/ -- Amprion, a global leader in the advancement of neurodegenerative disorder diagnosis, will be in attendance at the Alzheimers Association...

The Michael J. Fox Foundation for Parkinson's Research (MJFF), confirms the most significant breakthrough yet in the search for a Parkinson's biomarker: a biological test for Parkinson's disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise. The new test, known as the alpha-synuclein seed amplification assay (?Syn-SAA), heralds the revolutionary ability for research to define Pa...

A lab test for Parkinson’s focused on alpha-synuclein protein can help diagnose Parkinson’s disease before symptoms appear, a study found.

Identifying hallmark Parkinson’s disease misfolded protein deposits could aid early detection and pave the way for improved diagnosis and treatment.

New paper in The Lancet Neurology confirms that a key Parkinsons pathology can now be identified by examining spinal fluid from living patients Test validated...

New paper in The Lancet Neurology confirms that a key Parkinson's pathology can now be identified by examining spinal fluid from living patientsTest validated in the gold-standard Parkinson's

New paper in The Lancet Neurology confirms that a key Parkinsons pathology can now be identified by examining spinal fluid from living patients Test validated...

/PRNewswire/ -- Amprion is pleased to announce its attendance at the AD/PD™ 2023 International Conference on Alzheimers and Parkinsons Diseases and related...

San Francisco, CA (PRWEB) May 10, 2022 -- Amprion announces the National Institute of Neurological Disorders and Stroke (NINDS) has awarded an additional

Bill de Blasio, mayor of New York City, is standing by his sweeping vaccine mandates announced Monday, even saying in an interview with CNN that he believes it will protect businesses.